New study uses MRI to predict prostate cancer radiation success
NCT ID NCT06822491
First seen Nov 18, 2025 · Last updated May 20, 2026 · Updated 26 times
Summary
This study looks at 28 men with intermediate to high-risk prostate cancer who are getting a precise type of radiation called stereotactic body radiotherapy. The goal is to see if early MRI scans can show whether the main tumor is responding to treatment, and if that matches changes in PSA levels. Researchers hope this will help doctors know sooner if the radiation is working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Hospital Zurich
Zurich, 8091, Switzerland
Conditions
Explore the condition pages connected to this study.